Drug Supply Contracts with Accession Option
Arzneimittelverträge mit Beitrittsoption
Germany · Wuppertal · how to bid here →
Your path to submission
- Deadline: 1 February 2027 at 12:00 — 117 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 2 months (81 awards, most recently August 2026) — the next award is due around October 2026 by that rhythm. The last award went to BG Hexal 1 A Pharma GbR.n = 81
- The median procedure drew 6 bids (277 procedures with a bid count); 17% ended with a single bidder. Sector: median 2 bids.n = 277
- 50% of this buyer's awards went to companies that had already won here before (279 awards since 2024, spread over 134 companies). That is well below the sector norm (62%) — this buyer switches suppliers more often than others.n = 279 awards since 2024
- < 1% of the bids received came from other countries (149 procedures with a bid mix) — all bidders, not just the winners. Sector: 5%.n = 149
- From notice to award takes a median 137 days here (89 procedures). Sector: 90 days.n = 89
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 06/10/2026.
Foreign bidders
In Germany · Medical equipment & pharma, 265 contracts went to foreign companies over the last 3 years (of 22,200 recorded awards) — mostly from Austria, Netherlands, France.
Submission language: DEU.
Typical field: median 11 (from 81 awards).
What the buyer is looking for
The subject matter of the contract is medicinal products containing the active substance atovaquon. · The subject of the contract are medicinal products containing the active substance combination Bimatoprost + Timolol (EDO). · The subject of the contract are medicinal products containing the active substance budesonide (ATC A07EA06, HVW _KPG). · The subject of the contract are medicinal products containing the active substance chlortalidone. · The subject of the contract are medicinal products containing the active substance colchicine. · The subject of the contract are medicinal products containing the active substance dornase alfa. · The subject of the contract are medicinal products containing the active substance everolimus (ATC L04AH02, without TSE). · The subject of the contract are medicinal products containing the active substance fingolimod (0.25 mg). · The subject of the…
Show full description
… contract are medicinal products containing the active substance combination formoterol + glycopyrronium cation + budesonide. · The subject of the contract are medicinal products containing the active substance gefitinib. · The subject of the contract are medicinal products containing the active substance glycerol trinitrate (SPR _LOV). · The subject of the contract are medicinal products containing the active substance haloperidol (parenteral). · The subject of the contract are medicinal products containing the active substance isosorbide mononitrate. · The subject of the contract are medicinal products containing the active substance leuprorelin (IMP). · The subject of the contract are medicinal products containing the active substance leuprorelin (without IMP). · The subject of the contract are medicinal products containing the active substance lidocaine (PFL). · The subject of the contract are medicinal products containing the active substance loratadine (OTC, AM-RL Annex I). · The subject of the contract are medicinal products containing the active substance mercaptopurine (without SUE). · The subject of the contract are medicinal products containing the active substance mesalazine (KLI_RSU). · The subject of the contract are medicinal products containing the active substance mesalazine (oral, without retard in 0.5 g, 1.0 g, 2.0 g, 4.0 g). · The subject of the contract are medicinal products containing the active substance mesalazine (SUP_RSC). · The subject matter of the contract are medicinal products containing the active substance minocycline. · The subject of the contract are medicinal products containing the active substance minoxidil (ATC C02DC01). · The subject of the contract are medicinal products containing the active substance olanzapine (parenteral). · The subject of the contract are medicinal products that contain the active substance palonosetron (solid, oral). · The subject of the contract are medicinal products containing the active substance permethrin (OTC). · The subject of the contract are medicinal products containing the active substance pilocarpine. · The subject of the contract are medicinal products containing the active substance promethazine (liquid, oral). · The subject of the contract are medicinal products containing the active substance pyridostigminium cation (unretarded, oral, without LSE). · The subject of the contract are medicinal products containing the active substance tacrolimus (Advagraf®). · The subject of the contract are medicinal products containing the active substance tacrolimus (ATC D11AH01). · The subject of the contract are medicinal products containing the active substance tacrolimus (Prograf®). · The subject of the contract are medicinal products containing the active substance tacrolimus (RET). · The subject of the contract are medicinal products containing the active substance treprostinil (without 20 mg). · The subject of the contract are medicinal products containing the active substance vemurafenib.
Selection criteria — in the procurement documents
The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in German.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| AMAROX PHARMA GmbH · Haar | 6 | 2025–2026 |
| Zentiva Pharma GmbH · Frankfurt am Main | 6 | 2025–2026 |
| Basics GmbH · Leverkusen | 5 | 2026 |
| Werbeartikel Muesch e.K. · Troisdorf | 5 | 2024–2025 |
| T-Systems International GmbH · Düsseldorf | 5 | 2024–2025 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.